Page last updated: 2024-09-04

vx 497 and acetyl-aspartyl-glutamyl-valyl-aspartal

vx 497 has been researched along with acetyl-aspartyl-glutamyl-valyl-aspartal in 1 studies

Compound Research Comparison

Studies
(vx 497)
Trials
(vx 497)
Recent Studies (post-2010)
(vx 497)
Studies
(acetyl-aspartyl-glutamyl-valyl-aspartal)
Trials
(acetyl-aspartyl-glutamyl-valyl-aspartal)
Recent Studies (post-2010) (acetyl-aspartyl-glutamyl-valyl-aspartal)
2537268020

Protein Interaction Comparison

ProteinTaxonomyvx 497 (IC50)acetyl-aspartyl-glutamyl-valyl-aspartal (IC50)
Caspase-1Homo sapiens (human)0.0713
Caspase-3Homo sapiens (human)0.034
Caspase-2Homo sapiens (human)0.021
Caspase-7Homo sapiens (human)0.056
Caspase-6Homo sapiens (human)0.0077
Caspase-8Homo sapiens (human)0.0602

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1

Other Studies

1 other study(ies) available for vx 497 and acetyl-aspartyl-glutamyl-valyl-aspartal

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023